DEA

The Alliance for Connected Care led a letter signed by over 200 organizations in a letter to Terry Cole, Administrator of the Drug Enforcement Administration (DEA), requesting his leadership in ensuring that millions of Americans continue to have access to medically necessary health care through telemedicine after the current access deadline of December 31, [...]

The Alliance for Connected Care submitted input on the Office of National Drug Control Policy’s 2026 National Drug Control Strategy. The Alliance emphasized the importance of maintaining comprehensive access to telehealth, because it is often an essential part of treatment for mental health conditions and substance use disorders and supports long-term recovery. The Alliance urged ONDCP [...]

The Alliance appreciates the DEA’s forward movement on telemedicine prescribing of controlled substances policy. However, the Alliance continues to be concerned to see language in the proposed rulemaking mandating in-person visits as this is not an appropriate guardrail for a telehealth service. Similarly, restricting the geography in which telemedicine can be offered undermines the value [...]

If the DEA or Congress fail to enact an operationally feasible regulation for controlled substance prescribing via telehealth, thousands of patients risk losing access to vital, clinically appropriate medications. This could disrupt the care of patients dependent on remotely prescribed medications from a provider with whom they don’t have an in-person relationship (e.g. e-prescribed [...]

The Alliance for Connected Care led a letter, signed by more than 150 organizations, to the Attorney General Pam Bondi requesting her leadership in maintaining the access to telehealth that President Trump initiated during his first term. More than 150 organizations have signed this letter, including business groups like the Small Business & Entrepreneurship Council and [...]